Subject: Request from MoH Georgia regarding procuring Remdesivir
From: Maia Nikoleishvili <[email-masked]>
To: Pranjali <[email-masked]>
Cc: Vinay Dixit <[email-masked]>, Tamar Gabunia <[email-masked]>, Ekaterine Adamia <[email-masked]>, Alisa Tsuladze <[email-masked]>
Date: Wed, 07 Oct 2020 14:58:36 +0000

Dear Ms. Pranjali Singh Chauhan,

On behalf of the  Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Affairs of Georgia I would like to kindly send you letter signed by the Minister - Mrs. Ekaterine Tikaradze regarding procuring generic form
of Remdesivir manufactured under a license from Gilead Science Inc. for the treatment of the severe COVID-19 patients.

We would highly appreciate to receiving your feedback as soon as possible.

Thank you in advance.

Best regards,

Maia Nikoleishvili MPA

Head of International Relations and Protocol Division of Administration

Ministry of IDPs from the Occupied Territories, Labour, Health and Social Affairs of Georgia

Address: 144 Tsereteli ave., 0159 Tbilisi, Georgia

Tel.: +995 32 2510034 (0803)

Cell phone: +995 577272713

E-mail: [email-masked]

From: Pranjali

Sent: Wednesday, August 5, 2020 3:34 PM

To: info

Cc: 'Vinay Dixit'

Subject: Favipiravir for COVID treatment from Hetero, India

Dear Dr. Ekaterine Tikaradze,

We, Hetero Labs Limited, India would like to share that we have Favipiravir 200mg Tablet which can be used to treat COVID-19 patients in your country & we would like to join hands with you to combat this situation.  We request you to refer to the attached
letter for more details.

In case of any queries, feel free to contact the details mentioned in the letter.

Thanks & Regards,

Ms. Pranjali Singh Chauhan

Assistant Manager – CIS Countries

Hetero Labs Limited

[email-masked]

7-2-A2, Hetero Corporate, Industrial Estates, Sanath Nagar,

Hyderabad - 500018, Telangana, India.

Tel: +91 040 23704923 Ext No: 3299

www.heteroworld.com

|

Confidentiality Notice:

This e-mail transmission may contain confidential or legally privileged information that is intended only for the individual or entity named in the e-mail address. If you are not the intended recipient, you are hereby notified that any disclosure, copying,
distribution, or reliance upon the contents of this e-mail is strictly prohibited. If you have received this e-mail transmission in error, please delete the message and any attachments from your Inbox.